January 26, 2009 at 13:30 PM EST
Say No to Pfizer Drugs
Early this morning Pfizer (PFE) disseminated its fourth-quarter numbers. The New Yawk-based company beat estimates by $0.06. But frankly who cares? I think folks that play Pfizer these days need to be focused on what's going to happen down the road not just on its latest quarterly results. So how does the outlook appear say a year or so out? Mixed at best.Let’s take a quick gander at its $68 billion planned purchase of Wyeth (WYE) shall we? To be clear Wyeth does bring something to the table. After all it just finished up a year where it generated ...
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here